Eculizumab for paroxysmal nocturnal haemoglobinuria: catastrophic health expenditure in Nepalese patients.

Catastrophic health expenditure Eculizumab Low and middle-income countries Nepal Orphan drug Paroxysmal nocturnal hemoglobinuria

Journal

Orphanet journal of rare diseases
ISSN: 1750-1172
Titre abrégé: Orphanet J Rare Dis
Pays: England
ID NLM: 101266602

Informations de publication

Date de publication:
30 Jun 2023
Historique:
received: 12 11 2022
accepted: 18 06 2023
medline: 3 7 2023
pubmed: 1 7 2023
entrez: 30 6 2023
Statut: epublish

Résumé

Paroxysmal nocturnal hemoglobinuria (PNH) results from a mutation in the phosphatidylinositol glycan class-A gene which causes uncontrolled complement activation with resultant intravascular hemolysis and its sequelae. Eculizumab is a terminal complement inhibitor that blocks this complement activation and has revolutionized the treatment of PNH but comes with an enormous price which can have catastrophic health expenditure in low-middle income countries (LMIC) like Nepal. Here, we discuss the potential way forwards in the treatment of PNH in Nepal and other LMICs.

Identifiants

pubmed: 37391775
doi: 10.1186/s13023-023-02779-2
pii: 10.1186/s13023-023-02779-2
pmc: PMC10311788
doi:

Substances chimiques

eculizumab A3ULP0F556
Antibodies, Monoclonal, Humanized 0

Types de publication

Letter

Langues

eng

Sous-ensembles de citation

IM

Pagination

172

Informations de copyright

© 2023. The Author(s).

Références

Indian J Crit Care Med. 2016 Feb;20(2):117-9
pubmed: 27076714
Bull World Health Organ. 2002;80(8):612
pubmed: 12219150
Eur J Haematol. 2018 Dec;101(6):737-749
pubmed: 30171728
Blood. 2019 Feb 7;133(6):530-539
pubmed: 30510080
JNMA J Nepal Med Assoc. 2021 Feb 28;59(234):192-196
pubmed: 34506462
PLoS One. 2018 Apr 4;13(4):e0194564
pubmed: 29617393
J Nepal Health Res Counc. 2021 Jan 21;18(4):741-746
pubmed: 33510521
Cost Eff Resour Alloc. 2020 Oct 01;18:40
pubmed: 33013204
Lancet. 2009 Feb 28;373(9665):759-67
pubmed: 19144399
Lancet. 2003 Sep 20;362(9388):996; author reply 997
pubmed: 14511936
Int J Surg Case Rep. 2021 Oct;87:106445
pubmed: 34607268
Blood. 2021 Mar 11;137(10):1304-1309
pubmed: 33512400
N Engl J Med. 2006 Sep 21;355(12):1233-43
pubmed: 16990386
JNMA J Nepal Med Assoc. 2005 Jan-Mar;44(157):23-5
pubmed: 16082407
Haematologica. 2020 Oct 29;106(12):3188-3197
pubmed: 33121236
Bull World Health Organ. 2014 Oct 1;92(10):760-7
pubmed: 25378730
Blood. 2014 Oct 30;124(18):2804-11
pubmed: 25237200
Biol Blood Marrow Transplant. 2020 Oct;26(10):1833-1839
pubmed: 32512214
Eur J Haematol. 2018 Jul;101(1):3-11
pubmed: 29532535
Blood. 1951 Mar;6(3):270-84
pubmed: 14811916
Cureus. 2021 May 8;13(5):e14902
pubmed: 34109088
J Nephrol. 2022 May;35(4):1255-1257
pubmed: 35366215

Auteurs

Sugat Adhikari (S)

Shreegaun Primary Health Care Center, Dang, Nepal.

Surendra Sapkota (S)

Department of Internal Medicine, Ascension Saint Agnes Hospital, Baltimore, MD, USA.

Suraj Shrestha (S)

Maharajgunj Medical College, Institute of Medicine, Kathmandu, Nepal. multisurazz@gmail.com.

Kshitiz Karki (K)

Annapurna Neurological Institute and Allied Sciences, Kathmandu, Nepal.

Anjan Shrestha (A)

Department of Hematology, Tribhuvan University Teaching Hospital, Kathmandu, Nepal.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH